Moderna, Inc. (NASDAQ:MRNA – Free Report) – Stock analysts at Brookline Capital Markets raised their Q3 2026 earnings per share estimates for Moderna in a report released on Monday, August 31st. Brookline Capital Markets analyst L. Cann now forecasts that the company will post earnings per share of ($1.24) for the quarter, up from their […]

Moderna, Inc. (NASDAQ:MRNA – Free Report) – Equities researchers at Brookline Capital Markets reduced their FY2029 EPS estimates for shares of Moderna in a research report issued on Monday, August 31st. Brookline Capital Markets analyst L. Cann now anticipates that the company will post earnings per share of $11.54 for the year, down from their […]